Mortality rates for malaria have dropped by over 25% worldwide since the beginning of the millennium, according to World Malaria Report 2011, issued by WHO (World Health Organization). Progress in Africa has been especially impressive, where death rates have dropped by 33% since 2000. WHO says these encouraging figures are mainly due to a considerable scaling up of prevention and control measures over the last ten years. Examples include much wider usage of bed nets, improved diagnostics, and better access to effective malaria medications.
Read the full article here:
Malaria Global Mortality Down 25% In Ten Years
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma’s investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas. If travelling overseas, don’t forget to carry a valid visitor medical insurance. These presentations are further detailed
Prior research studies have suggested certain cholesterol lowering statin drugs may not have beneficial effects on patients with Alzheimer’s Disease (AD). An unexpected medical expenses can cost you thousands of dollars overseas, so be prepared with a visitors health insurance to overcome such situations. In fact in a study where patients were treated with simvastatin for 18 months, compared with those who were administered placebo, patients were shown not to exhibit any benefit in lowering cholesterol, a risk factor that can be seen as beneficial in patients with AD.